News & Updates

In people with knee osteoarthritis (OA) or are at high risk of such condition, dietary acrylamide seems to worsen physical performance and may potentially increase the risk of sarcopoenia, a recent study has found.

Selenium appears to reduce lipids and heighten the risk of type 2 diabetes (T2D), potentially via insulin resistance instead of pancreatic beta cell function, suggests a study.

Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.

In patients with multidrug-resistant hypertension (HTN), the blood pressure (BP)-lowering benefit of renal denervation (RDN) achieved at 2 months was amplified when a stepped-care medication escalation protocol was added between 2 and 6 months, updates from the RADIANCE-HTN TRIO trial have shown.

The introduction and use of chemoimmunotherapeutic agents such as rituximab, ofatumumab, and obinutuzumab has led to population-level improvements in survival from chronic lymphocytic leukaemia (CLL), a recent study has found.

About a third of patients who present to an emergency department with recent-onset low back pain fail to recover within 12 months, with factors such as higher pain levels and more pain sites, among others, being prognostic of complete nonrecovery within 6 months, according to a study.

In acute coronary syndrome (ACS) and stable angina pectoris (SAP) patients, undergoing surgery within a year after implantation of drug-eluting stent (DES) increases the risk of myocardial infarction (MI) and death, a recent study has found.